These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32623652)

  • 61. Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies.
    Paim-Marques LB; Cavalcante A; Castro C; Muskardin TLW; de Oliveira JB; Niewold TB; Appenzeller S
    Rheumatol Int; 2021 Jan; 41(1):219-225. PubMed ID: 32813153
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Canakinumab: a promising treatment in rheumatology].
    Fabreguet I; So A
    Rev Med Suisse; 2012 Jan; 8(323):57-60. PubMed ID: 22303742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review.
    Finetti M; Omenetti A; Federici S; Caorsi R; Gattorno M
    Orphanet J Rare Dis; 2016 Dec; 11(1):167. PubMed ID: 27927236
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Case of cryopyrin-associated periodic syndrome who recovered from growth delay by treatment with canakinumab.
    Yu Y; Watanabe R; Shibao K; Ishii Y; Nishikomori R; Heike T; Fujisawa Y; Furuta J
    J Dermatol; 2021 Feb; 48(2):e98-e99. PubMed ID: 33161611
    [No Abstract]   [Full Text] [Related]  

  • 65. Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.
    Russo RA; Melo-Gomes S; Lachmann HJ; Wynne K; Rajput K; Eleftheriou D; Edelsten C; Hawkins PN; Brogan PA
    Rheumatology (Oxford); 2014 Apr; 53(4):665-70. PubMed ID: 24352339
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Canakinumab, a monoclonal antibody against IL-1β, with potential utility in different inflammatory processes].
    Carné X
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():34-7. PubMed ID: 21596185
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature.
    Marchica C; Zawawi F; Basodan D; Scuccimarri R; Daniel SJ
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):9. PubMed ID: 29382382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low-frequency mosaicism in cryopyrin-associated periodic fever syndrome: mosaicism in systemic autoinflammatory diseases.
    Nishikomori R; Izawa K; Kambe N; Ohara O; Yasumi T
    Int Immunol; 2019 Sep; 31(10):649-655. PubMed ID: 31185077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The NLRP3 inflammasome: Physiopathology and therapeutic application].
    Gicquel T; Robert S; Victoni T; Lagente V
    Presse Med; 2016 Apr; 45(4 Pt 1):438-46. PubMed ID: 26880081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [CAPS: cryopyrin-associated periodic syndrome].
    Saito MK
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):369-77. PubMed ID: 22041424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An Adult Patient With a Novel Mutation in NLRP3 Gene Associated With Cryopyrin-Associated Periodic Syndrome Mimicking Adult-Onset Still Disease.
    Ocampo V; Ortiz-Sierra MC; Echeverri AF; Posso-Osorio I; Suso JP; Tobón GJ
    J Clin Rheumatol; 2018 Apr; 24(3):158-159. PubMed ID: 29239927
    [No Abstract]   [Full Text] [Related]  

  • 73. Secondary Intracranial Hypertension in Pediatric Patients With Cryopyrin-Associated Periodic Syndrome.
    Rogers DL; Akoghlanian S; Reem RE; Rogers S; Aylward SC
    Pediatr Neurol; 2020 Oct; 111():70-72. PubMed ID: 32951665
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model.
    Ma JH; Lee E; Yoon SH; Min H; Oh JH; Hwang I; Sung Y; Ryu JH; Bok J; Yu JW
    EBioMedicine; 2022 Aug; 82():104184. PubMed ID: 35870427
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Linkage of bacterial colonization of skin and the urticaria-like rash of NLRP3-mediated autoinflammatory syndromes through mast cell-derived TNF-α.
    Nakamura Y; Kambe N
    J Dermatol Sci; 2013 Aug; 71(2):83-8. PubMed ID: 23684246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism.
    Mensa-Vilaro A; Teresa Bosque M; Magri G; Honda Y; Martínez-Banaclocha H; Casorran-Berges M; Sintes J; González-Roca E; Ruiz-Ortiz E; Heike T; Martínez-Garcia JJ; Baroja-Mazo A; Cerutti A; Nishikomori R; Yagüe J; Pelegrín P; Delgado-Beltran C; Aróstegui JI
    Arthritis Rheumatol; 2016 Dec; 68(12):3035-3041. PubMed ID: 27273849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease.
    Sibley CH; Chioato A; Felix S; Colin L; Chakraborty A; Plass N; Rodriguez-Smith J; Brewer C; King K; Zalewski C; Kim HJ; Bishop R; Abrams K; Stone D; Chapelle D; Kost B; Snyder C; Butman JA; Wesley R; Goldbach-Mansky R
    Ann Rheum Dis; 2015 Sep; 74(9):1714-9. PubMed ID: 24906637
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes.
    Bujan-Rivas S; Basagaña M; Sena F; Méndez M; Dordal MT; Gonzalez-Roca E; Ruiz-Ortiz E; Mensa-Vilaró A; Plaza S; Modesto C; Ordi-Ros J; Yagüe J; Martínez-Valle F; Aróstegui JI
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):27-31. PubMed ID: 28079503
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.
    Yu JR; Leslie KS
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):12-20. PubMed ID: 21104172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.